High fluoroquinolone MIC is associated with fluoroquinolone treatment failure in urinary tract infections caused by fluoroquinolone susceptible Escherichia coli

BACKGROUND: Suboptimal clinical response to fluoroquinolone (FQ) therapy has been clearly documented in patients with Salmonella typhi infection with reduced FQ susceptibility. However, the clinical impact of reduced FQ susceptibility on other infections including E. coli urinary tract infections (U...

Descripción completa

Detalles Bibliográficos
Autores principales: Rattanaumpawan, Pinyo, Nachamkin, Irving, Bilker, Warren B., Roy, Jason A., Metlay, Joshua P., Zaoutis, Theoklis E., Lautenbach, Ebbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385084/
https://www.ncbi.nlm.nih.gov/pubmed/28390438
http://dx.doi.org/10.1186/s12941-017-0202-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385084/
https://www.ncbi.nlm.nih.gov/pubmed/28390438
http://dx.doi.org/10.1186/s12941-017-0202-4

Ejemplares similares